Article
Loss of Nuclear DNA Ligase III Reverts PARP Inhibitor Resistance in BRCA1/53BP1…
bioRxiv · 2021 · Mariana Paes Dias
Key facts
| Title | Loss of Nuclear DNA Ligase III Reverts PARP Inhibitor Resistance in BRCA1/53BP1 Double-deficient Cells by Exposing ssDNA Gaps |
|---|---|
| First author | Mariana Paes Dias |
| Journal | bioRxiv |
| Published | Jul 20, 2021 |
| DOI | 10.1101/2021.03.24.436323 |
| Devices mentioned | K050963, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967 and 12 more |
| Product codes mentioned | EBF, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, MOT and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1